Utility of Intermittent Cryo-Compression Versus Traditional Icing Following Arthroscopic Rotator Cuff Repair
Allina Health System · NCT05095909
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- August 5, 2024
- Record last updated
- January 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Effective post - operative pain control following orthopedic surgical procedures without excessive reliance upon opioid pain medication has garnered increased attention in recent years. This study will evaluate the utilization of a non-invasive, novel cryo - compression, post-operative modality to improve pain control versus standard ice wraps in the immediate post-operative phase of arthroscopic rotator cuff surgery via a randomized controlled study design. Furthermore, if this study demonstrates improved pain control, improved quality of life and decreased opioid usage with the intermittent cold compression unit, recommendations may be considered for system-wide utilization.
Being studied: Cryo-compression; Cryo-therapy
Conditions: Rotator Cuff Injuries; Cryotherapy Effect
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patients who are candidates for arthroscopic rotator cuff repair
- Acute, traumatic tear of the rotator cuff in an active patient
- Chronic, symptomatic tear of the rotator cuff in an active patient having failed non - operative treatment
- Patient agreeable to participation in the study and able to complete informed consent process and all study requirements.
- ≥18 years of age
Exclusion Criteria
- Pregnancy (per pre-operative physical)
- Presence of significant glenohumeral joint osteoarthritis
- Age over 70
- History of clinically diagnosed lymphedema
- Morbid obesity (BMI > 45)
- History of drug or alcohol addiction, prior opioid dependence, or current use of opioid medication (preoperative)
- Investigators concern regarding subject's ability or willingness to follow protocol.
- History of significant vascular impairment in the affected region (e.g., from prior frostbite, diabetes, arteriosclerosis or ischemia).
- History of acute paroxysmal cold hemoglobinuria or cryoglobulinemia.
- History of Raynaud's disease or cold hypersensitivity (cold urticarial).
Recruiting US locations
Allina Health Orthopedics
Plymouth, MN 55441
Site contact: Ned K Tervola, MA, LAT, ATC · 952-946-9777 · ned.tervola@allina.com
Study contacts (from the official record)
- Ned Tervola, MA, LAT, ATC · 952-946-9777 · ned.tervola@allina.com
Similar studies in Minnesota
All arthritis studies in Minnesota →- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Rochester, MN + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Amgen
- Location
- Rochester, MN + 12 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
AbbVie
- Location
- Minneapolis, MN + 11 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nkarta, Inc.
- Location
- Minneapolis, MN + 14 other US sites
- Eligibility basics
- Ages 18–75